HealthSouth Finalizes Purchase of Desert Canyon Rehabilitation Hospital

Thursday, June 3, 2010 Hospital News J E 4

BIRMINGHAM, Ala., June 2 HealthSouth Corporation (NYSE: HLS) today announced it has finalized its previously announced purchase of Desert Canyon Rehabilitation Hospital, a 50-bed inpatient rehabilitation hospital located in southwest Las Vegas, Nev.

"The acquisition of Desert Canyon Rehabilitation Hospital complements our existing presence in Las Vegas and reflects HealthSouth's renewed emphasis on disciplined growth that will bring additional value to our shareholders," said HealthSouth President and CEO, Jay Grinney.

"We welcome Desert Canyon Rehabilitation Hospital to HealthSouth's nationwide network of preeminent rehabilitation hospitals and look forward to building on the reputation for quality service this hospital has earned in southwest Las Vegas," said Jerry Gray, president of the West Region for HealthSouth.

This acquisition adds a third rehabilitation hospital location in Las Vegas, joining HealthSouth Rehabilitation Hospital of Henderson and HealthSouth Rehabilitation Hospital of Las Vegas. HealthSouth also operates a long-term acute care hospital, HealthSouth Hospital of Tenaya, and a home health agency in Henderson.

About HealthSouth

HealthSouth is the nation's largest provider of inpatient rehabilitative healthcare services. Operating in 26 states across the country and in Puerto Rico, HealthSouth serves patients through its network of inpatient rehabilitation hospitals, long-term acute care hospitals, outpatient rehabilitation satellite clinics, and home health agencies. HealthSouth strives to be the nation's preeminent provider of inpatient rehabilitative healthcare services and can be found on the Web at

Media Contact ------------- Andy Brimmer / Helen Todd, 205-410-2777 Investor Relations Contact -------------------------- Mary Ann Arico, 205-969-6175

SOURCE HealthSouth Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
GSK Announces Revised Product Labels for Serevent®...
TeamStaff Receives Nasdaq Deficiency Notice Regard...